Insider Transactions Reported by 22 Insiders of Vaxcyte, Inc.

Symbol
PCVX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
San Carlos, CA

Insiders trading volume in the past year

Vaxcyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jeff Fairman VP, Research $22.9M Dec 30, 2022
Grant Pickering CHIEF EXECUTIVE OFFICER, Director $21M Sep 8, 2025
Jim Wassil Chief Operating Officer $4.79M -$1.95M -28.9% Sep 8, 2025
Andrew Guggenhime President And Cfo $4.22M -$2.07M -32.9% Sep 8, 2025
Mikhail Eydelman Svp, Gen Counsel & Corp Sec $3.01M -$1.23M -29% Mar 5, 2025
Harpreet S. Dhaliwal Chief Technical Ops Officer $1.09M Sep 8, 2025
Peter Hirth Director $1.04M Jun 6, 2024
Elvia Cowan Svp, Finance $848K Sep 8, 2025
Halley E. Gilbert Director $742K Jun 12, 2025
Heath Lukatch Director $499K Jun 12, 2025
Michael E. Kamarck Director $364K Jun 13, 2023
Anne S. Drapeau Director $296K Jun 12, 2025
Teri Loxam Director $296K -$532K -64.2% Jun 12, 2025
Carlos V. Paya Director $296K Jun 12, 2025
Jane Wright-Mitchell General Counsel $202K Aug 16, 2021
Jacks Lee Director $133K Jun 12, 2025
John Furey Director $88.2K Jun 12, 2025
Olivier Brandicourt Director $33.3K Jun 12, 2025
Paul Sauer SVP Process Dev, Manufacturing Dec 30, 2022
Kurt Von Emster Director Jun 2, 2021
Patrick J. Heron Director Jun 2, 2021
Robert Lorne Hopfner Director Jun 2, 2021

Recent Insider Transactions by Companies or Individuals for Vaxcyte, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.